BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa.
Mike L T BerendsenSjors Wl van GijzelJeroen SmitsQuirijn de MastPeter AabyChristine S BennMihai G NeteaAndre Jam van der VenPublished in: BMJ global health (2019)
BCG vaccination is associated with protection against malaria. This protection is highest in regions with suboptimal BCG coverage. These results indicate a possible role for timely BCG vaccination in the protection of malaria and its elimination by reducing the transmission reservoir. If confirmed in further research, our findings have substantial implications for global efforts to reduce malaria burden.